BRPI0924016A2 - par de primer para diagnóstico de distrofia corneana de avellino - Google Patents

par de primer para diagnóstico de distrofia corneana de avellino

Info

Publication number
BRPI0924016A2
BRPI0924016A2 BRPI0924016A BRPI0924016A BRPI0924016A2 BR PI0924016 A2 BRPI0924016 A2 BR PI0924016A2 BR PI0924016 A BRPI0924016 A BR PI0924016A BR PI0924016 A BRPI0924016 A BR PI0924016A BR PI0924016 A2 BRPI0924016 A2 BR PI0924016A2
Authority
BR
Brazil
Prior art keywords
avellin
diagnosis
primer pair
corneal dystrophy
dystrophy
Prior art date
Application number
BRPI0924016A
Other languages
English (en)
Inventor
Gene Lee
Jung Kuk Yun
Original Assignee
Avellino Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avellino Co Ltd filed Critical Avellino Co Ltd
Publication of BRPI0924016A2 publication Critical patent/BRPI0924016A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2561/00Nucleic acid detection characterised by assay method
    • C12Q2561/113Real time assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BRPI0924016A 2009-04-17 2009-12-01 par de primer para diagnóstico de distrofia corneana de avellino BRPI0924016A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020090033528A KR101251538B1 (ko) 2009-04-17 2009-04-17 아벨리노 각막이상증 진단용 프라이머
PCT/KR2009/007099 WO2010120027A1 (ko) 2009-04-17 2009-12-01 아벨리노 각막이상증 진단용 프라이머

Publications (1)

Publication Number Publication Date
BRPI0924016A2 true BRPI0924016A2 (pt) 2016-10-11

Family

ID=42982670

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0924016A BRPI0924016A2 (pt) 2009-04-17 2009-12-01 par de primer para diagnóstico de distrofia corneana de avellino

Country Status (13)

Country Link
US (4) US20120077200A1 (pt)
EP (2) EP2420574B1 (pt)
JP (1) JP5738842B2 (pt)
KR (1) KR101251538B1 (pt)
CN (3) CN110872613A (pt)
AU (1) AU2009344501A1 (pt)
BR (1) BRPI0924016A2 (pt)
CA (1) CA2759222A1 (pt)
IL (1) IL215845A0 (pt)
RU (1) RU2534817C2 (pt)
SG (1) SG175732A1 (pt)
WO (1) WO2010120027A1 (pt)
ZA (1) ZA201107967B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101251538B1 (ko) * 2009-04-17 2013-04-08 (주)아벨리노 아벨리노 각막이상증 진단용 프라이머
KR101125212B1 (ko) * 2010-10-01 2012-03-21 (주)아벨리노 아벨리노 각막이상증 진단용 시스템
KR101480522B1 (ko) 2013-02-15 2015-01-08 솔젠트 (주) 아벨리노 각막 이상증 판별용 진단 키트
EP3486328B1 (en) 2013-03-15 2020-11-11 Avellino Lab USA, Inc. Methods for improved isolation of genomic dna templates for allele detection
KR101577109B1 (ko) * 2013-04-23 2015-12-11 주식회사 녹십자엠에스 아벨리노 각막이상증 진단용 조성물 및 이의 진단방법
SG10201804076RA (en) * 2013-11-15 2018-06-28 Avellino Lab Usa Inc Methods for multiplex detection of alleles associated with ophthalmic conditions
KR20180120670A (ko) 2015-11-13 2018-11-06 아벨리노 랩 유에스에이, 인크. 각막 이상증의 치료 방법
CN106480200A (zh) * 2016-10-25 2017-03-08 北京亿昊基因技术有限公司 一种快速高效的与角膜营养不良相关基因突变位点的检测方法
CN108085375B (zh) * 2016-11-07 2020-10-16 北京华大通瀛科技有限公司 检测角膜营养不良基因多态性位点的基因型的方法及其试剂盒
KR101957919B1 (ko) * 2017-01-02 2019-03-13 부산대학교 산학협력단 각막이상증 진단용 바이오센서 및 이의 용도
KR20200129539A (ko) 2019-05-09 2020-11-18 주식회사 왓슨알앤디 Pcr 및 제한효소를 이용한 각막이상증 분자 진단 방법.
KR102249878B1 (ko) 2019-09-24 2021-05-11 주식회사 에이엠에스바이오 과립형 각막이상증 진단용 조성물

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6018713A (en) 1997-04-09 2000-01-25 Coli; Robert D. Integrated system and method for ordering and cumulative results reporting of medical tests
JP3380744B2 (ja) 1998-05-19 2003-02-24 株式会社日立製作所 センサおよびこれを利用した測定装置
US6171112B1 (en) 1998-09-18 2001-01-09 Wyngate, Inc. Methods and apparatus for authenticating informed consent
AU4135600A (en) 1999-03-29 2000-10-16 Genset Prostate cancer associated human fibronectin gene and biallelic markers
ATE381626T1 (de) 2000-04-13 2008-01-15 Univ Georgetown Genetische diagnose zur feststellung von qt- verlängerungen als unerwünschte reaktion auf arzneimittel
US8438042B2 (en) 2002-04-25 2013-05-07 National Biomedical Research Foundation Instruments and methods for obtaining informed consent to genetic tests
JP2005511013A (ja) 2001-08-09 2005-04-28 キュラジェン コーポレイション 核酸、ポリペプチド、一塩基多型、およびそれらの使用方法
AU2002352069A1 (en) 2001-11-28 2003-06-10 Graffinity Pharmaceuticals Ag Surface plasmon resonance (spr) sensor surface support
US20030211141A1 (en) * 2001-12-11 2003-11-13 Lebaron Richard G. Genetic and protein manipulation of betaIG-H3 for the treatment and cure of muscular dystrophies
US6943417B2 (en) 2003-05-01 2005-09-13 Clemson University DNA-based memory device and method of reading and writing same
US20050019757A1 (en) 2003-06-12 2005-01-27 Stolarchuk Danylo J. Contaminant detection apparatus
WO2005015198A1 (ja) 2003-08-06 2005-02-17 Nippon Telegraph And Telephone Corporation 多孔質材料を用いた分子の検出方法ならびに該多孔質材料及び該多孔質材料の製造方法
US20070212542A1 (en) 2003-10-22 2007-09-13 The Regents Of The University Of California Methods for Preparing and Functionalizing Nanoparticles
JP2007512807A (ja) 2003-10-28 2007-05-24 バイエル ヘルスケア アーゲー 悪性腫瘍の処置に対する応答予測のための方法および組成物
EP1541528A1 (en) 2003-12-08 2005-06-15 Institut Jozef Stefan Quasi-one-dimensional polymers based on the metal-chalcogen-halogen system
US20060057604A1 (en) 2004-03-15 2006-03-16 Thinkfar Nanotechnology Corporation Method for electrically detecting oligo-nucleotides with nano-particles
ZA200610693B (en) 2004-05-19 2008-06-25 Vp Holding Llc Optical sensor with layered plasmon structure for enhanced detection of chemical groups by sers
US7713849B2 (en) 2004-08-20 2010-05-11 Illuminex Corporation Metallic nanowire arrays and methods for making and using same
US7332329B2 (en) 2004-09-24 2008-02-19 Wisconsin Alumni Research Foundation Versatile substrate for SPR detection
WO2006096011A1 (en) * 2005-03-08 2006-09-14 Medigenes Co., Ltd. PHARMACEUTICAL COMPOSITION FOR TREATING AVELLINO CORNEA DYSTROPHY COMPRISING AN ANTIBODY AGAINST TGF-β
JP2006250668A (ja) 2005-03-10 2006-09-21 Tatsuro Endo 非標識バイオチップ
EP1715326A1 (en) 2005-04-22 2006-10-25 Universität Heidelberg Sensor chip with connected non-metallic particles comprising a metallic coating
WO2007002567A2 (en) 2005-06-23 2007-01-04 Nanosphere, Inc. Selective isolation and concentration of nucleic acids from complex samples
KR20070076532A (ko) 2006-01-18 2007-07-24 메디제네스(주) 각막이영양증 진단용 dna 칩
CN101374850A (zh) * 2006-01-18 2009-02-25 株式会社美迪基尼斯 用于角膜营养不良诊断的dna芯片
MX2008012026A (es) 2006-03-21 2008-11-04 Univ Washington Polimorfismos geneticos en el gen de hormona que libera corticotropina (crh) como marcadores para mejorar el registro de marmoleo de carne de res y/o profundidad de grasa subcutanea.
RU2348695C2 (ru) * 2006-05-23 2009-03-10 Закрытое акционерное общество "Молекулярно-медицинские технологии" Дифференцирующий и специфический олигонуклеотиды для идентификации последовательностей днк инфекционных агентов в биологических материалах, способ видовой идентификации инфекционных агентов, биочип и набор для осуществления этого способа
EP1932922A1 (de) 2006-12-13 2008-06-18 Desitin Arzneimittel GmbH Schnelltest zum Nachweis von DNA-Sequenzen
US20080176320A1 (en) 2007-01-16 2008-07-24 Applera Corporation Selective Lysis of Sperm Cells
US7898658B2 (en) 2007-01-23 2011-03-01 The Regents Of The University Of California Platform for chemical and biological sensing by surface-enhanced Raman spectroscopy
KR100891096B1 (ko) 2007-02-13 2009-03-31 삼성전자주식회사 올리고머 프로브 어레이 및 이의 제조 방법
JP5222599B2 (ja) 2007-07-20 2013-06-26 株式会社日立ハイテクノロジーズ 核酸分析デバイス及びそれを用いた核酸分析装置
CN101144812B (zh) 2007-10-17 2012-02-22 中国科学院光电技术研究所 一种局域表面等离子体生化传感器的制作方法
US20120231537A1 (en) 2008-04-30 2012-09-13 Gradalis, Inc. Highly Pure Plasmid DNA Preparations
KR101251538B1 (ko) * 2009-04-17 2013-04-08 (주)아벨리노 아벨리노 각막이상증 진단용 프라이머
US8865402B2 (en) 2009-08-26 2014-10-21 Clemson University Research Foundation Nanostructured substrates for surface enhanced raman spectroscopy (SERS) and detection of biological and chemical analytes by electrical double layer (EDL) capacitance
KR101125212B1 (ko) 2010-10-01 2012-03-21 (주)아벨리노 아벨리노 각막이상증 진단용 시스템
SG10201804076RA (en) 2013-11-15 2018-06-28 Avellino Lab Usa Inc Methods for multiplex detection of alleles associated with ophthalmic conditions

Also Published As

Publication number Publication date
US20220205044A1 (en) 2022-06-30
JP2012523831A (ja) 2012-10-11
KR20100115030A (ko) 2010-10-27
RU2534817C2 (ru) 2014-12-10
KR101251538B1 (ko) 2013-04-08
WO2010120027A1 (ko) 2010-10-21
CA2759222A1 (en) 2010-10-21
EP2420574A4 (en) 2012-08-29
EP2420574A1 (en) 2012-02-22
JP5738842B2 (ja) 2015-06-24
US20150093751A1 (en) 2015-04-02
AU2009344501A1 (en) 2011-11-17
US11268146B2 (en) 2022-03-08
CN104774930A (zh) 2015-07-15
CN110872613A (zh) 2020-03-10
EP2420574B1 (en) 2014-10-29
US20180274034A1 (en) 2018-09-27
RU2011146553A (ru) 2013-05-27
CN102459593A (zh) 2012-05-16
IL215845A0 (en) 2012-01-31
US9938581B2 (en) 2018-04-10
US20120077200A1 (en) 2012-03-29
ZA201107967B (en) 2013-08-28
EP2848689A1 (en) 2015-03-18
CN102459593B (zh) 2015-04-08
SG175732A1 (en) 2011-12-29

Similar Documents

Publication Publication Date Title
BRPI0924016A2 (pt) par de primer para diagnóstico de distrofia corneana de avellino
SMT201600424B (it) Emulsione oftalmica
SMT201600254B (it) Procedimento per la preparazione di idromagnesite
ES2626488T8 (es) Procedimientos para la síntesis de ácidos nucleicos funcionalizados
ES2685958T8 (es) Procedimiento para la detección temprana de trenes
BR112013021368A2 (pt) implante, especialmente para oclusão de abeurismas bifurcais
UY33094A (es) Procedimiento para la preparacion de dronedarona
SMT201600464B (it) Procedimento per la preparazione di esterolo
BR112012000687A2 (pt) tesoura para um endoscópio
BRPI1006128A2 (pt) derivados de sulfonamida
ES2603028T8 (es) Procedimiento para la preparación de (Z)-alfa-fluoro-beta-amino-acrilaldehídos sustituidos
BRPI1008744A2 (pt) hidrotratamento de caboidratos
CO6970598A2 (es) Derivados de 4-pregenen-11ss-17-21-triol-3,20-diona para el tratamiento de afecciones oculares
DK2872497T4 (da) Chromanyl-derivater til behandling af mitokondriel sygdom
BR112014003660A2 (pt) suporte de trocarte
ES2547827T8 (es) Procedimiento para la purificación de la micafungina
CO6960557A2 (es) Derivados de 2-yodo-imidazol
IT1402029B1 (it) Procedimento per la preparazione di erlotinib
BRPI1010740A2 (pt) novos derivados de ciclopentano
BRPI1012139A2 (pt) balanceador de volume variado para purificação do sangue
BR112013010270A2 (pt) polimorfos de febuxostato
CO6852074A2 (es) Novedosos derivados de ftalazinona-pirrolopirimidinacarboxamida
BR112013030881A2 (pt) acoplamento para uma bolsa de ostomia, e, método para anexar uma bolsa de ostomia
BR112014007022A2 (pt) composição farmacêutica para melhoria de absorção do trato gastrointestinal
IT1404000B1 (it) Manipolatore semi-attivo per chirurgia articolare non invasiva

Legal Events

Date Code Title Description
B11Z Dismissal: petition dismissal - article 216, par 2 of industrial property law

Free format text: PROMULGA-SE O ARQUIVAMENTO DA PETICAO DE ENTRADA NA FASE NACIONAL PELA AUSENCIA DE APRESENTACAO DA PROCURACAO CONFORME APRESENTADO NO ART. 216 2O DA LPI (LEI 9279/1996) E DA RESOLUCAO INPI-PR NO 77/2013, ART. 31. DESTA DATA, CORRE O PRAZO DE 60 (SESSENTA) DIAS PARA EVENTUAL RECURSO DO INTERESSADO CONFORME APRESENTADO NO ART. 212 DA LPI (LEI 9279/1996) E DA RESOLUCAO INPI-PR NO 77/2013, ART. 31, PARAGRAFO UNICO.

B11N Dismissal: publication cancelled [chapter 11.14 patent gazette]

Free format text: ANULACAO DA PUBLICACAO CODIGO 11.6.1 NA RPI NO 2327 DE 11/08/2015, POR TER SIDO INDEVIDA.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]